rs35536751

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015450.3(POT1):​c.1211G>T​(p.Gly404Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 1,612,590 control chromosomes in the GnomAD database, including 242 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G404D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.011 ( 25 hom., cov: 32)
Exomes 𝑓: 0.014 ( 217 hom. )

Consequence

POT1
NM_015450.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0320
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021687746).
BP6
Variant 7-124841131-C-A is Benign according to our data. Variant chr7-124841131-C-A is described in ClinVar as [Benign]. Clinvar id is 475029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-124841131-C-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0107 (1624/151974) while in subpopulation NFE AF= 0.0144 (976/67828). AF 95% confidence interval is 0.0136. There are 25 homozygotes in gnomad4. There are 821 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 25 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POT1NM_015450.3 linkuse as main transcriptc.1211G>T p.Gly404Val missense_variant 14/19 ENST00000357628.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POT1ENST00000357628.8 linkuse as main transcriptc.1211G>T p.Gly404Val missense_variant 14/192 NM_015450.3 P1Q9NUX5-1

Frequencies

GnomAD3 genomes
AF:
0.0107
AC:
1626
AN:
151856
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00239
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00505
Gnomad ASJ
AF:
0.0690
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0104
Gnomad FIN
AF:
0.0151
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0144
Gnomad OTH
AF:
0.0101
GnomAD3 exomes
AF:
0.0136
AC:
3422
AN:
250782
Hom.:
45
AF XY:
0.0142
AC XY:
1924
AN XY:
135540
show subpopulations
Gnomad AFR exome
AF:
0.00253
Gnomad AMR exome
AF:
0.00359
Gnomad ASJ exome
AF:
0.0663
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0120
Gnomad FIN exome
AF:
0.0143
Gnomad NFE exome
AF:
0.0161
Gnomad OTH exome
AF:
0.0154
GnomAD4 exome
AF:
0.0144
AC:
20998
AN:
1460616
Hom.:
217
Cov.:
31
AF XY:
0.0145
AC XY:
10540
AN XY:
726642
show subpopulations
Gnomad4 AFR exome
AF:
0.00251
Gnomad4 AMR exome
AF:
0.00324
Gnomad4 ASJ exome
AF:
0.0687
Gnomad4 EAS exome
AF:
0.0000506
Gnomad4 SAS exome
AF:
0.0136
Gnomad4 FIN exome
AF:
0.0136
Gnomad4 NFE exome
AF:
0.0144
Gnomad4 OTH exome
AF:
0.0156
GnomAD4 genome
AF:
0.0107
AC:
1624
AN:
151974
Hom.:
25
Cov.:
32
AF XY:
0.0111
AC XY:
821
AN XY:
74296
show subpopulations
Gnomad4 AFR
AF:
0.00238
Gnomad4 AMR
AF:
0.00504
Gnomad4 ASJ
AF:
0.0690
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0104
Gnomad4 FIN
AF:
0.0151
Gnomad4 NFE
AF:
0.0144
Gnomad4 OTH
AF:
0.00950
Alfa
AF:
0.0149
Hom.:
9
Bravo
AF:
0.00972
TwinsUK
AF:
0.0105
AC:
39
ALSPAC
AF:
0.0143
AC:
55
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0163
AC:
140
ExAC
AF:
0.0136
AC:
1646
Asia WGS
AF:
0.00289
AC:
10
AN:
3476
EpiCase
AF:
0.0151
EpiControl
AF:
0.0155

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxDec 28, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalAug 15, 2023- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoApr 02, 2021- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 03, 2023- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024POT1: BP4, BS1, BS2 -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Tumor predisposition syndrome 3 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 14, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
12
DANN
Benign
0.79
DEOGEN2
Benign
0.20
T;T;T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.042
N
LIST_S2
Benign
0.69
T;T;.
MetaRNN
Benign
0.0022
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.1
N;N;.
REVEL
Benign
0.058
Sift
Benign
0.052
T;T;.
Sift4G
Benign
0.21
T;T;T
Polyphen
0.0020
B;.;.
Vest4
0.12
MPC
0.11
ClinPred
0.0086
T
GERP RS
-1.5
Varity_R
0.092
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35536751; hg19: chr7-124481185; COSMIC: COSV99052288; API